Back to BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP

GLUEGLUE
Showing 8 of 14 quarters

Position history for BAKER BROS. ADVISORS LPBAKER BROS. ADVISORS LP's holdings in MONTE ROSA THERAPEUTICS INC

Yes. Baker Bros. Advisors holds 4,345,736 shares of GLUE (Monte Rosa Therapeutics), worth $105.2M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Baker Bros. Advisors has held GLUE since Q1 2023, across 14 quarterly 13F filings. GLUE is 0.5% of Baker Bros. Advisors' reported 13F portfolio.

Current Value

$105.2M

Current Shares

4.3M

Total Value Change

+$79.1M

Total Shares Change

-570,359

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
4.3M
0.0%
$105.2M0.5%$24.20
0
2026-Q1
Unchanged
4.3M
0.0%
$71.5M0.4%$17.96
0
2025-Q4
Decreased
4.3M
-11.6%
$68.1M0.4%$15.97
0
2025-Q3
Unchanged
4.9M
0.0%
$36.4M0.3%$7.31
0
2025-Q2
Unchanged
4.9M
0.0%
$22.2M0.2%$4.60
0
2025-Q1
Unchanged
4.9M
0.0%
$22.8M0.3%$5.10
0
2024-Q4
Unchanged
4.9M
0.0%
$34.1M0.4%$7.02
0
2024-Q3
Unchanged
4.9M
0.0%
$26.1M0.3%$5.17
0

Other major holders of GLUE: PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used